TOT BIOPHARM INTERNATIONAL COMPANY LIMITED

Other languages TOT BIOPHARM International Company Limited

Equities

1875

HK0000545266

Delayed Hong Kong S.E. Other stock markets 04:08:06 2024-04-30 am EDT			5-day change	1st Jan Change
1.74 ^HKD	-.--%		+12.99%	-11.68%

Mar. 15	TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	TOT Biopharm's Loss Narrows in January-September Period	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15
TOT Biopharm's Loss Narrows in H1	23-08-14
TOT BIOPHARM International Company Limited Announces Directorate and Committee Changes	23-08-11
TOT BIOPHARM International Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-11
TOT BIOPHARM's Q1 Loss Widens Despite Higher Revenue	23-05-12
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23
TOT Biopharm Terminates Phase 3 Trial of Breast Cancer Drug; Shares Fall 5%	23-03-20
TOT BIOPHARM International Company Limited Announces Termination of Phase III Clinical Trial Study and Development of Taa013	23-03-17
TOT Biopharm International Logs Reduction in H1 Net Loss; Shares Climb 3%	22-08-15
TOT BIOPHARM International Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-12
TOT Biopharm Narrows Loss on Lower Selling, R&D Expenses in 2021	22-03-24
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-24
TOT BIOPHARM International Company Limited Announces Change of Directors and Change of Composition of Board Committees	22-03-13
TOT BIOPHARM International Company Limited Announces Change of Joint Company Secretary and Finance Personnel	22-01-31
TOT Biopharm Narrows Loss in January-September as Revenue Doubles; Shares Rally 4%	21-11-09
TOT BIOPHARM International Company Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended 30 June 2021	21-09-16
TOT BIOPHARM International Company Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2021	21-08-12
TOT BIOPHARM International : Cancer Drug Wins Registration, Marketing Approvals in China; Shares Jump 5%	21-05-31
TOT BIOPHARM International : Trims Loss in Q1	21-05-11
TOT BIOPHARM International Company Limited Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2021	21-05-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages TOT BIOPHARM International Company Limited

Equities

1875

HK0000545266

Other languages

Filters